TRANEXAMIC ACID | N022430 | J MOLNER HOLDINGS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D.N.J. | 2023-06-28 | Terminated 2023-12-27 | — | |
| D. Nev. | 2012-11-09 | Terminated 2015-06-11 | — | |
Ferring B.V. v. Watson Pharmaceuticals, Inc. Florida, et al 1 patentANDA 202093tranexamic acid | D. Nev. | 2011-11-25 | Terminated 2015-06-11 | — |
| D. Nev. | 2011-07-08 | Terminated 2014-03-24 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Appco Pharma LLC FDA-2026-P-5578 · 6 docket documents Appco Pharma LLC filed a suitability petition requesting that the FDA establish that a drug substance is suitable for use as an active pharmaceutical ingredient in an NDA formulation, specifically for use in developing a new drug product that would be manufactured and distributed by Appco Pharma. | Suitability | 2026-05-14 | Open | Appco Pharma LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.8567
per ea
Lowest NADAC/Unit
$0.8567
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 69918030130TRANEXAMIC ACID 650 MG TABLET | $0.8567 | EA | Generic | — | 2026-08-19 |
| 50268077213TRANEXAMIC ACID 650 MG TABLET | $0.8567 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.